Abstract:Proteolytic processing of amyloid precursor protein (APP) plays a critical role in the pathogenesis of Azheimer's disease (AD). Sequential cleavage of APP by β and γ secretases leads to generation of Aβ40 (non-amyloidogenic) and Aβ42 (amyloidogenic) peptides. Despite intense studies, the biological function of these peptides and the mechanism of Aβ42 toxicity is poorly understood. In the previous publications we proposed that association of Aβ peptides with the endosomal membranes may have important implications for pathogenesis of AD (Kim and Bezprozvanny, IJMS, 2021, vol 22, 13600; Kim and Bezprozvanny, IJMS, 2023, vol 24, 2092). To understand potential biological importance of such interaction, we focused on the region of Aβ peptides involved in peri-membrane association (E682 to N698). We discovered that association of this region with the membranes is reminiscent of several known anti-microbial peptides (AMP) such as PA13, Aurein1.2 and BP100. Our analysis further revealed that energy of peri-membrane association of Aβ40 is significantly weaker than for Aβ42 or AMP peptides, but it can be increased in the presence of non-amyloidogenic FAD mutations or in the presence of cholesterol in the membrane. Based on similarity with established mechanism of action of AMP peptides, we propose that Aβ peptides affect the curvature of endosomal membranes and shift the balance between endosomal recycling to plasma membrane and late endosomal/lysosomal pathway. We further propose that these effects are enhanced as a result of non-amyloidogenic FAD mutations in the sequence of Aβ peptides or in the presence of cholesterol in the membrane. The proposed model provides potential mechanistic explanation to synaptic defects induced by increased levels of Aβ42, by non-amyloidogenic FAD mutations in APP and by age-related increase in the levels of cholesterol in the brain.

Antimicrobial Peptides in the Brain Neuropeptides and Amyloid

Antimicrobial Peptides in the Brain

Antimicrobial neuropeptides and their therapeutic potential in vertebrate brain infectious disease

Amyloid Peptides with Antimicrobial And/or Microbial Agglutination Activity

Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration

Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides?

A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology

Antimicrobial peptides in the gut-brain axis: A straightforward review to unravel some missing links

Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity

Antimicrobial Peptides (AMPs): Roles, Functions and Mechanism of Action

Construction of Unified Human Antimicrobial and Immunomodulatory Peptide Database and Examination of Antimicrobial and Immunomodulatory Peptides in Alzheimer’s Disease Using Network Analysis of Proteomics Datasets

Research Advances of Cationic Antimicrobial Peptides in the Immune Response in Sepsis

Little Antimicrobial Peptides with Big Therapeutic Roles

The role of natural antimicrobial peptides during infection and chronic inflammation

Bioactivity and application prospect of antimicrobial peptide

Biological function of Aβ peptides revealed by analysis of membrane-association properties: Implications for Azheimer's disease pathogenesis

Diversity and Mechanisms of Action of Plant, Animal, and Human Antimicrobial Peptides

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease

Mechanistic insights into the role of amyloid-β in innate immunity

Bioactivity, Action Mechanism and Application of Antimicrobial Peptides

The Antimicrobial Peptides and Their Potential Clinical Applications.